236 related articles for article (PubMed ID: 36387279)
1. A cutting-edge immunomodulatory interlinkage between HOTAIR and MALAT1 in tumor-associated macrophages in breast cancer: A personalized immunotherapeutic approach.
Amer HT; Eissa RA; El Tayebi HM
Front Mol Biosci; 2022; 9():1032517. PubMed ID: 36387279
[TBL] [Abstract][Full Text] [Related]
2. The Monocyte, a Maestro in the Tumor Microenvironment (TME) of Breast Cancer.
Amer HT; Stein U; El Tayebi HM
Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358879
[TBL] [Abstract][Full Text] [Related]
3. NEAT1: Culprit lncRNA linking PIG-C, MSLN, and CD80 in triple-negative breast cancer.
Hussein NH; Eissa RA; de Bruyn M; El Tayebi HM
Life Sci; 2022 Jun; 299():120523. PubMed ID: 35378140
[TBL] [Abstract][Full Text] [Related]
4. Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer.
Adewunmi O; Shen Y; Zhang XH; Rosen JM
Cancer Immunol Res; 2023 Nov; 11(11):1462-1479. PubMed ID: 37603945
[TBL] [Abstract][Full Text] [Related]
5. Taraxacum mongolicum extract inhibited malignant phenotype of triple-negative breast cancer cells in tumor-associated macrophages microenvironment through suppressing IL-10 / STAT3 / PD-L1 signaling pathways.
Deng XX; Jiao YN; Hao HF; Xue D; Bai CC; Han SY
J Ethnopharmacol; 2021 Jun; 274():113978. PubMed ID: 33716082
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated macrophages of the M1/M2 phenotype are involved in the regulation of malignant biological behavior of breast cancer cells through the EMT pathway.
Chen Z; Wu J; Wang L; Zhao H; He J
Med Oncol; 2022 May; 39(5):83. PubMed ID: 35570226
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNAs XIST and MALAT1 hijack the PD-L1 regulatory signaling pathway in breast cancer subtypes.
Samir A; Tawab RA; El Tayebi HM
Oncol Lett; 2021 Aug; 22(2):593. PubMed ID: 34149904
[TBL] [Abstract][Full Text] [Related]
8. The Streptococcus virulence protein PepO triggers anti-tumor immune responses by reprograming tumor-associated macrophages in a mouse triple negative breast cancer model.
Liu B; Huang J; Xiao J; Xu W; Zhang H; Yuan Y; Yin Y; Zhang X
Cell Biosci; 2023 Nov; 13(1):198. PubMed ID: 37925462
[TBL] [Abstract][Full Text] [Related]
9. Antitumor therapy for breast cancer: Focus on tumor-associated macrophages and nanosized drug delivery systems.
Zhan C; Jin Y; Xu X; Shao J; Jin C
Cancer Med; 2023 May; 12(10):11049-11072. PubMed ID: 36794651
[TBL] [Abstract][Full Text] [Related]
10. Targeting molecular cross-talk between tumor cells and tumor associated macrophage as therapeutic strategy in triple negative breast cancer.
Shettigar A; Salunke R; Modi D; Mukherjee N
Int Immunopharmacol; 2023 Jun; 119():110250. PubMed ID: 37163922
[TBL] [Abstract][Full Text] [Related]
11. Delicaflavone reactivates anti-tumor immune responses by abrogating monocytic myeloid cell-mediated immunosuppression.
Li L; You W; Wang X; Zou Y; Yao H; Lan H; Lin X; Zhang Q; Chen B
Phytomedicine; 2023 Jan; 108():154508. PubMed ID: 36332384
[TBL] [Abstract][Full Text] [Related]
12. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
13. Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness.
Pe KCS; Saetung R; Yodsurang V; Chaotham C; Suppipat K; Chanvorachote P; Tawinwung S
PLoS One; 2022; 17(8):e0273044. PubMed ID: 35960749
[TBL] [Abstract][Full Text] [Related]
14. A vicious circle in breast cancer: The interplay between inflammation, reactive oxygen species, and microRNAs.
Villarreal-García V; Estupiñan-Jiménez JR; Vivas-Mejía PE; Gonzalez-Villasana V; Vázquez-Guillén JM; Reséndez-Pérez D
Front Oncol; 2022; 12():980694. PubMed ID: 36226048
[TBL] [Abstract][Full Text] [Related]
15. Tumor microenvironment in triple-negative breast cancer: the correlation of tumor-associated macrophages and tumor-infiltrating lymphocytes.
Kuroda H; Jamiyan T; Yamaguchi R; Kakumoto A; Abe A; Harada O; Masunaga A
Clin Transl Oncol; 2021 Dec; 23(12):2513-2525. PubMed ID: 34089486
[TBL] [Abstract][Full Text] [Related]
16. Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.
Jadaliha M; Zong X; Malakar P; Ray T; Singh DK; Freier SM; Jensen T; Prasanth SG; Karni R; Ray PS; Prasanth KV
Oncotarget; 2016 Jun; 7(26):40418-40436. PubMed ID: 27250026
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Associated Macrophages: Protumoral Macrophages in Inflammatory Tumor Microenvironment.
Malekghasemi S; Majidi J; Baghbanzadeh A; Abdolalizadeh J; Baradaran B; Aghebati-Maleki L
Adv Pharm Bull; 2020 Sep; 10(4):556-565. PubMed ID: 33062602
[TBL] [Abstract][Full Text] [Related]
18. The MALAT1-breast cancer interplay: insights and implications.
Tufail M
Expert Rev Mol Diagn; 2023; 23(8):665-678. PubMed ID: 37405385
[TBL] [Abstract][Full Text] [Related]
19. CAFs Interacting With TAMs in Tumor Microenvironment to Enhance Tumorigenesis and Immune Evasion.
Gunaydin G
Front Oncol; 2021; 11():668349. PubMed ID: 34336660
[TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNA
Cantile M; Di Bonito M; Cerrone M; Collina F; De Laurentiis M; Botti G
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32397382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
